FTO and hepatocellular carcinoma: Additionally, CS2, another FTO inhibitor, in combination with anti-PD-1 therapy, significantly promoted the infiltration of CD45 + F4/80 + macrophages, particularly antitumoral M1 macrophages, in spontaneous HCC tumors.